Biotech Values

[DewDiligence]

The insatiable cash-burning machine commonly known as Vertex is going back to the trough, even though it already had $832M of cash as of 12/31/08:

http://finance.yahoo.com/news/Vertex-Pharmaceuticals-bw-14403827.html

As noted in #msg-35470983, during 2009 VRTX will surpass Millennium Pharmaceuticals for the dubious honor of having the largest cumulative losses from corporate inception of any biotech company, ever.